# A Multicenter Clinical Study on the Continuous vs. Intermittent Infusion of Ceftazidime-Avibactam in Critically Ill Patients With Severe Infections

> **NCT06939829** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Southeast University, China** · enrollment: 1200 (estimated)

## Conditions studied

- Patients With Critically Ill Infections

## Interventions

- **DRUG:** treatment with CAZ-AVI

## Key facts

- **NCT ID:** NCT06939829
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2025-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06939829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06939829, "A Multicenter Clinical Study on the Continuous vs. Intermittent Infusion of Ceftazidime-Avibactam in Critically Ill Patients With Severe Infections". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06939829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*